Insulet Corp: Form 10-K for the period ended Dec 31, 2012
Filed with the SEC on Feb 28, 2013 and accepted by EDGAR at Feb 28, 2013, 19:49 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2012-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2012-10-01 to 2012-12-31 | $57.8m | us-gaap:SalesRevenueNet |
| Revenue | 12 months2012-01-01 to 2012-12-31 | $211.4m | us-gaap:SalesRevenueNet |
| Cost of revenue | 12 months2012-01-01 to 2012-12-31 | $119.0m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2012-10-01 to 2012-12-31 | $25.3m | us-gaap:GrossProfit |
| Gross profit | 12 months2012-01-01 to 2012-12-31 | $92.3m | us-gaap:GrossProfit |
| Research and development | 12 months2012-01-01 to 2012-12-31 | $24.4m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 12 months2012-01-01 to 2012-12-31 | −$36.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2012-01-01 to 2012-12-31 | $212.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2012-10-01 to 2012-12-31 | −$10.2m | us-gaap:NetIncomeLoss |
| Net income | 12 months2012-01-01 to 2012-12-31 | −$51.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2012-10-01 to 2012-12-31 | −$0.21 | us-gaap:EarningsPerShareBasicAndDiluted |
| Diluted EPS | 12 months2012-01-01 to 2012-12-31 | −$1.08 | us-gaap:EarningsPerShareBasicAndDiluted |
| Operating cash flow | 12 months2012-01-01 to 2012-12-31 | −$29.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2012-01-01 to 2012-12-31 | $11.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2012-12-31 | $57.3m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2012-12-31 | $109.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2012-12-31 | $198.1m | us-gaap:Assets |
| Current liabilities | At period end2012-12-31 | $48.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2012-12-31 | $153.9m | us-gaap:Liabilities |
| Long-term debt | At period end2012-12-31 | $103.7m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2012-12-31 | $14.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2012-12-31 | $44.2m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-13-083670. Last ingested by Listed: Nov 4, 2026, 16:38 ET. Listed shows no prices and gives no investment advice.